BRIEF published on 06/03/2026 at 19:59, 3 months 9 days ago Median Technologies lève 50 millions d'euros lors d'une augmentation de capital Augmentation De Capital Diagnostics Basés Sur L'IA Base D'actionnaires Sursouscription Du Marché Déploiement Eyonis®
PRESS RELEASE published on 06/03/2026 at 19:54, 3 months 9 days ago Informations privilégiées / Autres communiqués Median Technologies annonce le vif succès de son augmentation de capital de 50 millions d'euros. Opération sursouscrite, soutien du marché fort, déploiement commercial d'eyonis® LCS et nouvelles indications cliniques Investisseurs Institutionnels Augmentation De Capital Median Technologies Diagnostic Précoce Eyonis® LCS
PRESS RELEASE published on 06/03/2026 at 19:54, 3 months 9 days ago Inside Information / Other news releases Median Technologies successfully completes €50 million capital increase without shareholders' preferential subscription rights. Funds to deploy eyonis® LCS in U.S. and Europe and expand clinical indications Investment Capital Increase Median Technologies Eyonis® LCS Clinical Indications
BRIEF published on 05/21/2026 at 17:50, 3 months 22 days ago Median Technologies Publishes Shareholder Meeting Documents Voting Rights Shareholders’ Meeting Euronext Growth Median Technologies Documents Availability
BRIEF published on 05/21/2026 at 17:50, 3 months 22 days ago Median Technologies publie les documents de l'assemblée générale des actionnaires Droit De Vote Euronext Croissance Assemblée Générale Des Actionnaires Technologies Médianes Disponibilité Des Documents
PRESS RELEASE published on 05/21/2026 at 17:45, 3 months 22 days ago Terms of availability of the information and the report on corporate governance Median Technologies releases preparatory documents for the Annual Shareholders’ Meeting on June 10, 2026. Shareholders can access documents on the company's website Shareholders General Meeting Annual Shareholders’ Meeting Preparatory Documents Median Technologies
BRIEF published on 03/30/2026 at 15:19, 5 months 13 days ago Median Technologies Achieves ISO 13485:2016 Certification ISO 13485:2016 Regulatory Standards Oncology Solutions Eyonis® AI-based SaMD
BRIEF published on 03/30/2026 at 15:19, 5 months 13 days ago Median Technologies obtient la certification ISO 13485:2016 ISO 13485:2016 Normes Réglementaires Logiciel Basé Sur L'IA Solutions En Oncologie Eyonis®
PRESS RELEASE published on 03/30/2026 at 15:14, 5 months 13 days ago Inside Information / Other news releases Median Technologies achieves ISO 13485:2016 certification for eyonis® Medical Device Quality Management System, reinforcing commitment to safe and reliable oncology solutions Median Technologies AI-based Software Oncology Solutions ISO 13485:2016 Certification Eyonis Medical Device
BRIEF published on 02/12/2026 at 22:10, 7 months ago Median Technologies and Tempus Partner to Expand Lung Cancer Screening in the U.S. FDA Clearance Median Technologies Lung Cancer Screening Eyonis® LCS Tempus AI
Published on 09/12/2026 at 02:35, 1 day 4 hours ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 1 day 8 hours ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 21:25, 1 day 9 hours ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 1 day 14 hours ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 17:50, 13 hours 20 minutes ago New Delhi Marks UN Day for South-South Cooperation with Push to Scale Dryland Innovation Across the Global South
Published on 09/12/2026 at 07:30, 23 hours 40 minutes ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 1 day 8 hours ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 1 day 9 hours ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 1 day 11 hours ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 07:00, 2 days ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 2 days ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 2 days 11 hours ago Availability of the 2026 Interim Financial Report
